Stockreport

BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com
PDF Biomarker data suggest ALS patients may benefit from longer-term treatment with NurOwnPoster highlighting design of planned Phase 3b NurOwn trial also presentedNEW YORK, [Read more]